To report the prevalence and severity of nonpelvic symptoms for patients with venous-origin chronic pelvic pain (VO-CPP) and to describe outcomes after pelvic vein stenting and embolization.
Methods
We retrospectively reviewed outcomes of 45 women with VO-CPP who underwent treatment with iliac vein stenting and/or embolization. Patients completed symptom-severity questionnaires before and after treatment that assessed for pelvic pain, and multiple other symptoms, including brain fog, anxiety, depression, musculoskeletal pain, fatigue, migraines and more.
Results
Patient age ranged from 18 to 65 years. The prevalence of common symptoms was as follows: migraines, 69%; brain fog, 76%; anxiety attacks, 58%; excess sweating, 64%; hip pain, 73%; diarrhea, 62%; constipation, 76%; and abdominal bloating, 82%. After treatment, most symptom scores improved by more than 50%; exceptions were excessive sweating (41% improvement) and bloating (47% improvement). Prevalence of individual symptoms that bundle into POTS ranged from 29% to 76%, where symptom improvement ranged from 23% to 59% after treatment. Overlapping individual symptoms characteristic of fibromyalgia and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) were present in 64% to 82% of patients and all improved by 49% to 63% after treatment.
Conclusions
Pelvic venous flow abnormality is linked causally to a spectrum of interrelated symptoms, of which many can be bundled into named syndromes of unknown cause. With catheter- based treatment of pelvic venous pooling, nonpelvic symptom and syndrome scores improved.
SmithSJSichlauMJSmithBH, et al.Improvement in chronic pelvic pain, orthostatic intolerance and interstitial cystitis symptoms after treatment of pelvic vein insufficiency. Phlebology2024; 39: 202–213. DOI: 10.1177/02683555231219737.
2.
SmithSJSichlauMSewallLE, et al.An online survey of pelvic congestion support group members regarding comorbid symptoms and syndromes. Phlebology2022; 37(8): 596–601. DOI: 10.1177/02683555221112567.
3.
Dos SantosSJWhiteleyMS. Pelvic congestion syndrome masquerading as osteoarthritis of the hip. SAGE Open Med Case Rep2016; 4: 2050313X16683630. DOI: 10.1177/2050313X16683630.
4.
ShelkeyJHuangCKarpaK, et al.Case report: pelvic congestion syndrome as an unusual etiology for chronic hip pain in 2 active, middle-age women. Sport Health2014; 6(2): 145–148. DOI: 10.1177/1941738113481940.
5.
AaronLAHerrellRAshtonS, et al.Comorbid clinical conditions in chronic fatigue: a co-twin control study. J Gen Intern Med2001; 16(1): 24–31. DOI: 10.1111/j.1525-1497.2001.03419.x.
6.
AaronLABuchwaldD. A review of the evidence for overlap among unexplained clinical conditions. Ann Intern Med2001; 134(9 Pt 2): 868–881. DOI: 10.7326/0003-4819-134-9_part_2-200105011-00011.
7.
TaylorHC. Vascular congestion and hyperemia; their effect on function and structure in the female reproductive organs; the clinical aspects of the congestion-fibrosis syndrome. Am J Obstet Gynecol1949; 57(4): 637–653. DOI: 10.1016/0002-9378(49)90704-8.
8.
SeoJGParkSP. Significance of fatigue in patients with migraine. J Clin Neurosci2018; 50: 69–73. DOI: 10.1016/j.jocn.2018.01.032.
9.
StubberudACheemaSTronvikE, et al.Nutcracker syndrome mimicking new daily persistent headache: a case report. Cephalalgia2020; 40(9): 1008–1011. DOI: 10.1177/0333102420918554.
10.
RossAJMedowMSRowePC, et al.What is brain fog? An evaluation of the symptom in postural tachycardia syndrome. Clin Auton Res2013; 23(6): 305–311. DOI: 10.1007/s10286-013-0212-z.
11.
MackKJJohnsonJNRowePC. Orthostatic intolerance and the headache patient. Semin Pediatr Neurol2010; 17(2): 109–116. DOI: 10.1016/j.spen.2010.04.006.
12.
RomaMMardenCLDe WandeleI, et al.Postural tachycardia syndrome and other forms of orthostatic intolerance in Ehlers-Danlos syndrome. Auton Neurosci2018; 215: 89–96. DOI: 10.1016/j.autneu.2018.02.006.
13.
HakimADe WandeleIO'CallaghanC, et al.Chronic fatigue in Ehlers-Danlos syndrome-Hypermobile type. Am J Med Genet C Semin Med Genet2017; 175(1): 175–180. DOI: 10.1002/ajmg.c.31542.
14.
Bou-HolaigahICalkinsHFlynnJA, et al.Provocation of hypotension and pain during upright tilt table testing in adults with fibromyalgia. Clin Exp Rheumatol1997; 15(3): 239–246.
15.
van CampenCRowePCVerheugtFWA, et al.Orthostatic stress testing in myalgic encephalomyelitis/chronic fatigue syndrome patients with or without concomitant fibromyalgia: effects on pressure pain thresholds and temporal summation. Clin Exp Rheumatol2021; 10(3): 39–47. DOI: 10.55563/clinexprheumatol/1qj9zu.
16.
ChelimskyGSimpsonPMcCabeNcollaborative, et al. Autonomic testing in women with chronic pelvic pain. J Urol2016; 196(2): 429–434. DOI: 10.1016/j.juro.2016.03.142.
17.
StewartJM. Autonomic nervous system dysfunction in adolescents with postural orthostatic tachycardia syndrome and chronic fatigue syndrome is characterized by attenuated vagal baroreflex and potentiated sympathetic vasomotion. Pediatr Res2000; 48(2): 218–226. DOI: 10.1203/00006450-200008000-00016.
18.
UlasUHChelimskyTCChelimskyG, et al.Comorbid health conditions in women with syncope. Clin Auton Res2010; 20(4): 223–227. DOI: 10.1007/s10286-010-0070-x.
19.
RiedlASchmidtmannMStengelA, et al.Somatic comorbidities of irritable bowel syndrome: a systematic analysis. J Psychosom Res2008; 64(6): 573–582. DOI: 10.1016/j.jpsychores.2008.02.021.
20.
AaronLABurkeMMBuchwaldD. Overlapping conditions among patients with chronic fatigue syndrome, fibromyalgia, and temporomandibular disorder. Arch Intern Med2000; 160(2): 221–227. DOI: 10.1001/archinte.160.2.221.
21.
MazurMFurgalaAJablonskiK, et al.Autonomic nervous system activity in constipation-predominant irritable bowel syndrome patients. Med Sci Mon Int Med J Exp Clin Res2012; 18(8): 493–499. DOI: 10.12659/msm.883269.
22.
WhiteheadWEPalssonOJonesKR. Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications?Gastroenterology2002; 122(4): 1140–1156. DOI: 10.1053/gast.2002.32392.
23.
Aubry-RozierBSchwitzguebelAValerioF, et al.Are patients with hypermobile Ehlers-Danlos syndrome or hypermobility spectrum disorder so different?Rheumatol Int2021; 41(10): 1785–1794. DOI: 10.1007/s00296-021-04968-3.
24.
CastoriMCellettiCCamerotaF. Ehlers-Danlos syndrome hypermobility type: a possible unifying concept for various functional somatic syndromes. Rheumatol Int2013; 33(3): 819–821. DOI: 10.1007/s00296-011-2275-2.
25.
DahanHShirYVellyA, et al.Specific and number of comorbidities are associated with increased levels of temporomandibular pain intensity and duration. J Headache Pain2015; 16: 528. DOI: 10.1186/s10194-015-0528-2.
26.
De WandeleICaldersPPeersmanW, et al.Autonomic symptom burden in the hypermobility type of Ehlers-Danlos syndrome: a comparative study with two other EDS types, fibromyalgia, and healthy controls. Semin Arthritis Rheum2014; 44(3): 353–361. DOI: 10.1016/j.semarthrit.2014.05.013.
27.
De WandeleIRombautLLeybaertL, et al.Dysautonomia and its underlying mechanisms in the hypermobility type of Ehlers-Danlos syndrome. Semin Arthritis Rheum2014; 44(1): 93–100. DOI: 10.1016/j.semarthrit.2013.12.006.
28.
FairweatherDBrunoKADarakjianAA, et al.High overlap in patients diagnosed with hypermobile Ehlers-Danlos syndrome or hypermobile spectrum disorders with fibromyalgia and 40 self-reported symptoms and comorbidities. Front Med2023; 10: 1096180. DOI: 10.3389/fmed.2023.1096180.
29.
GlayzerJEMcFarlinBLCastoriM, et al.High rate of dyspareunia and probable vulvodynia in Ehlers-Danlos syndromes and hypermobility spectrum disorders: an online survey. Am J Med Genet C Semin Med Genet2021; 187(4): 599–608. DOI: 10.1002/ajmg.c.31939.
30.
PollackBvon SaltzaEMcCorkellL, et al.Female reproductive health impacts of Long COVID and associated illnesses including ME/CFS, POTS, and connective tissue disorders: a literature review. Front Rehabil Sci2023; 4: 1122673. DOI: 10.3389/fresc.2023.1122673.
31.
PuleddaFViganoACellettiC, et al.A study of migraine characteristics in joint hypermobility syndrome a.k.a. Ehlers-Danlos syndrome, hypermobility type. Neurol Sci2015; 36(8): 1417–1424. DOI: 10.1007/s10072-015-2173-6.
JohanssonMStahlbergMRunoldM, et al.Long-haul post-COVID-19 symptoms presenting as a variant of postural orthostatic tachycardia syndrome: the Swedish experience. JACC Case Rep2021; 3(4): 573–580. DOI: 10.1016/j.jaccas.2021.01.009.
WagnerCIsenmannSRingendahlH, et al.Anxiety in patients with postural tachycardia syndrome (POTS). Fortschr Neurol Psychiatr2012; 80(8): 458–462. DOI: 10.1055/s-0031-1299106.
36.
ClaytonEW. Beyond myalgic encephalomyelitis/chronic fatigue syndrome: an IOM report on redefining an illness. JAMA2015; 313(11): 1101–1112. DOI: 10.1001/jama.2015.1346.
37.
De WandeleIRombautLDe BackerT, et al.Orthostatic intolerance and fatigue in the hypermobility type of Ehlers-Danlos Syndrome. Rheumatology2016; 55(8): 1412–1420. DOI: 10.1093/rheumatology/kew032.
38.
van CampenCVerheugtFWARowePC, et al.Cerebral blood flow is reduced in ME/CFS during head-up tilt testing even in the absence of hypotension or tachycardia: a quantitative, controlled study using Doppler echography. Clin Neurophysiol Pract2020; 5: 50–58. DOI: 10.1016/j.cnp.2020.01.003.
39.
ArnoldLMClauwDJMcCarbergBHFibroCollaborative. Improving the recognition and diagnosis of fibromyalgia. Mayo Clin Proc2011; 86(5): 457–464. DOI: 10.4065/mcp.2010.0738.
40.
BeardRWReginaldPWWadsworthJ. Clinical features of women with chronic lower abdominal pain and pelvic congestion. Br J Obstet Gynaecol1988; 95(2): 153–161. DOI: 10.1111/j.1471-0528.1988.tb06845.x.
41.
RitelliMVenturiniMCinquinaV, et al.Multisystemic manifestations in a cohort of 75 classical Ehlers-Danlos syndrome patients: natural history and nosological perspectives. Orphanet J Rare Dis2020; 15(1): 197. DOI: 10.1186/s13023-020-01470-0.
42.
ThwaitesPAGibsonPRBurgellRE. Hypermobile Ehlers-Danlos syndrome and disorders of the gastrointestinal tract: what the gastroenterologist needs to know. J Gastroenterol Hepatol2022; 37(9): 1693–1709. DOI: 10.1111/jgh.15927.
43.
CuiJGaoZBlahaC, et al.Distension of central great vein decreases sympathetic outflow in humans. Am J Physiol Heart Circ Physiol2013; 305(3): 378–385. DOI: 10.1152/ajpheart.00019.2013.
44.
StewartJMMontgomeryLD. Regional blood volume and peripheral blood flow in postural tachycardia syndrome. Am J Physiol Heart Circ Physiol2004; 287(3): 1319–1327. DOI: 10.1152/ajpheart.00086.2004.
45.
StewartJMTanejaIMedowMS. Reduced central blood volume and cardiac output and increased vascular resistance during static handgrip exercise in postural tachycardia syndrome. Am J Physiol Heart Circ Physiol2007; 293(3): 1908–1917. DOI: 10.1152/ajpheart.00439.2007.
46.
van CampenCLMCRowePCVisserFC. Compression stockings improve cardiac output and cerebral blood flow during tilt testing in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) patients: a randomized crossover trial. Medicina2021; 58(1): 51. DOI: 10.3390/medicina58010051.
47.
ZamunerARBarbicFDipaolaF, et al.Relationship between sympathetic activity and pain intensity in fibromyalgia. Clin Exp Rheumatol2015; 33(1 Suppl 88): 53–57.
48.
GavrilovSGVasilievaGYVasilievIM, et al.Calcitonin gene-related peptide and substance P as predictors of venous pelvic pain. Acta Naturae2019; 11(4): 88–92. DOI: 10.32607/20758251-2019-11-4-88-92.
49.
von ElmEAltmanDGEggerMSTROBE Initiative, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol2008; 61(4): 344–349. DOI: 10.1016/j.jclinepi.2007.11.008.
50.
O'RourkeM. The invisible kingdom: reimagining chronic illness. New York, NY: Riverhead Books, 2022, p. 324.
51.
KimHSMalhotraADRowePC, et al.Embolotherapy for pelvic congestion syndrome: long-term results. J Vasc Intervent Radiol2006; 17(2 Pt 1): 289–297. DOI: 10.1097/01.RVI.0000194870.11980.F8.
52.
O'SullivanGSmithS. Deep venous stenting in females. CVIR Endovasc2023; 6(1): 14. DOI: 10.1186/s42155-023-00354-1.
53.
KnuttinenMGZurcherKSKhuranaN, et al.Imaging findings of pelvic venous insufficiency in patients with postural orthostatic tachycardia syndrome. Phlebology2020; 36(1): 268355520947610. DOI: 10.1177/0268355520947610.
54.
IbraheemWMcKenzieSWilcox-OmuboV, et al.Pathophysiology and clinical implications of cognitive dysfunction in fibromyalgia. Cureus2021; 13(10): e19123. DOI: 10.7759/cureus.19123.
55.
van CampenCRowePCVerheugtFWA, et al.Cognitive function declines following orthostatic stress in adults with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Front Neurosci2020; 14: 688. DOI: 10.3389/fnins.2020.00688.
56.
Al-AlyZTopolE. Solving the puzzle of long covid. Science2024; 383(6685): 830–832. DOI: 10.1126/science.adl0867.
57.
KwanACEbingerJEWeiJ, et al.Apparent risks of postural orthostatic tachycardia syndrome diagnoses after COVID-19 vaccination and SARS-cov-2 infection. Nat Cardiovasc Res2022; 1(12): 1187–1194. DOI: 10.1038/s44161-022-00177-8.
58.
ClauwDJ. Fibromyalgia: an overview. Am J Med2009; 122(12 Suppl): S3–S13. DOI: 10.1016/j.amjmed.2009.09.006.
59.
WilliamsDAClauwDJ. Understanding fibromyalgia: lessons from the broader pain research community. J Pain2009; 10(8): 777–791. DOI: 10.1016/j.jpain.2009.06.001.
60.
MalfaitFFrancomanoCByersP, et al.The 2017 international classification of the Ehlers-Danlos syndromes. Am J Med Genet C Semin Med Genet2017; 175(1): 8–26. DOI: 10.1002/ajmg.c.31552.
61.
TinkleBTBirdHAGrahameR, et al.The lack of clinical distinction between the hypermobility type of Ehlers-Danlos syndrome and the joint hypermobility syndrome (a.k.a. hypermobility syndrome). Am J Med Genet2009; 149A(11): 2368–2370. DOI: 10.1002/ajmg.a.33070.
62.
Martinez-LavinM. Biology and therapy of fibromyalgia. Stress, the stress response system, and fibromyalgia. Arthritis Res Ther2007; 9(4): 216. DOI: 10.1186/ar2146.
63.
BulbenaAGagoJPailhezG, et al.Joint hypermobility syndrome is a risk factor trait for anxiety disorders: a 15-year follow-up cohort study. Gen Hosp Psychiatr2011; 33(4): 363–370. DOI: 10.1016/j.genhosppsych.2011.03.004.
64.
CastoriMColombiM. Generalized joint hypermobility, joint hypermobility syndrome and Ehlers-Danlos syndrome, hypermobility type. Am J Med Genet C Semin Med Genet2015; 169C(1): 1–5. DOI: 10.1002/ajmg.c.31432.
65.
TiborLMSekiyaJK. Differential diagnosis of pain around the hip joint. Arthroscopy2008; 24(12): 1407–1421. DOI: 10.1016/j.arthro.2008.06.019.
66.
PekerACamkertenGTBalciA, et al.Increased prevalence of pelvic venous congestion sign on sacroiliac MRI in women with clinically suspected sacroiliitis. North Clin Istanb2020; 7(6): 551–556. DOI: 10.14744/nci.2020.48030.
67.
BurchRRizzoliPLoderE. The prevalence and impact of migraine and severe headache in the United States: figures and trends from government health studies. Headache2018; 58(4): 496–505. DOI: 10.1111/head.13281.
68.
GazeraniPCairnsBE. Dysautonomia in the pathogenesis of migraine. Expert Rev Neurother2018; 18(2): 153–165. DOI: 10.1080/14737175.2018.1414601.
69.
PiovesanEJSobreiraCFScolaRH, et al.Episodic migraine associated with postural orthostatic tachycardia syndrome and vasovagal syncope: migraine triggers neuromediated syncope. Arq Neuropsiquiatr2008; 66(1): 77–79. DOI: 10.1590/s0004-282x2008000100018.
70.
LohkampLNMaratheNFehlingsMG. Craniocervical instability in ehlers-danlos syndrome-A systematic review of diagnostic and surgical treatment criteria. Global Spine J2022; 12(8): 1862–1871. DOI: 10.1177/21925682211068520.
71.
CuglanBOnalanAOzturkS, et al.Venous leg symptoms in patients with migraine: a potential clue on the pathophysiology of migraine (Vein-Migraine study). Eur Heart J2021; 42(Supplement_1). DOI: 10.1093/eurheartj/ehab724.1980.
72.
AshinaMHansenJMDoTP, et al.Migraine and the trigeminovascular system-40 years and counting. Lancet Neurol2019; 18(8): 795–804. DOI: 10.1016/S1474-4422(19)30185-1.
73.
RuziehMBaughADasaO, et al.Effects of intermittent intravenous saline infusions in patients with medication-refractory postural tachycardia syndrome. J Intervent Card Electrophysiol2017; 48(3): 255–260. DOI: 10.1007/s10840-017-0225-y.
74.
TaylorHC. Vascular congestion and hyperemia; their effect on structure and function in the female reproductive system. Am J Obstet Gynecol1949; 57(2): 211–230. DOI: 10.1016/0002-9378(49)90422-6.
75.
DeLucaJJohnsonSKEllisSP, et al.Cognitive functioning is impaired in patients with chronic fatigue syndrome devoid of psychiatric disease. J Neurol Neurosurg Psychiatry1997; 62(2): 151–155. DOI: 10.1136/jnnp.62.2.151.
76.
KanjwalKKarabinBKanjwalY, et al.Autonomic dysfunction presenting as orthostatic intolerance in patients suffering from mitochondrial cytopathy. Clin Cardiol2010; 33(10): 626–629. DOI: 10.1002/clc.20805.
77.
NovakP. Post COVID-19 syndrome associated with orthostatic cerebral hypoperfusion syndrome, small fiber neuropathy and benefit of immunotherapy: a case report. eNeurologicalSci2020; 21: 100276. DOI: 10.1016/j.ensci.2020.100276.
78.
OkamotoLERajSRPeltierA, et al.Neurohumoral and haemodynamic profile in postural tachycardia and chronic fatigue syndromes. Clin Sci2012; 122(4): 183–192. DOI: 10.1042/CS20110200.
79.
WangLWangFSGershwinME. Human autoimmune diseases: a comprehensive update. J Intern Med2015; 278(4): 369–395. DOI: 10.1111/joim.12395.
80.
CarboneFFikreeAAzizQ, et al.Joint hypermobility syndrome in patients with functional dyspepsia. Clin Transl Gastroenterol2020; 11(11): e00220. DOI: 10.14309/ctg.0000000000000220.
LewisIPairmanJSpickettG, et al.Clinical characteristics of a novel subgroup of chronic fatigue syndrome patients with postural orthostatic tachycardia syndrome. J Intern Med2013; 273(5): 501–510. DOI: 10.1111/joim.12022.
83.
NeeJKilaruSKelleyJ, et al.Prevalence of functional gi diseases and pelvic floor symptoms in marfan syndrome and ehlers-danlos syndrome: a national cohort study. J Clin Gastroenterol2019; 53(9): 653–659. DOI: 10.1097/MCG.0000000000001173.
84.
TaiFWDPalssonOSLamCY, et al.Functional gastrointestinal disorders are increased in joint hypermobility-related disorders with concomitant postural orthostatic tachycardia syndrome. Neuro Gastroenterol Motil2020; 32(12): e13975. DOI: 10.1111/nmo.13975.
85.
MorrissRKAhmedMWeardenAJ, et al.The role of depression in pain, psychophysiological syndromes and medically unexplained symptoms associated with chronic fatigue syndrome. J Affect Disord1999; 55(2-3): 143–148. DOI: 10.1016/s0165-0327(98)00218-3.
86.
MitakidesJTinkleBT. Oral and mandibular manifestations in the Ehlers-Danlos syndromes. Am J Med Genet C Semin Med Genet2017; 175(1): 220–225. DOI: 10.1002/ajmg.c.31541.
87.
SmolinskaSWiniarskaEGlobinskaA, et al.Histamine: a mediator of intestinal disorders-A review. Metabolites2022; 12(10): 895. DOI: 10.3390/metabo12100895.
88.
TheoharidesTCTwahirAKempurajD. Mast cells in the autonomic nervous system and potential role in disorders with dysautonomia and neuroinflammation. Ann Allergy Asthma Immunol2024; 132(4): 440–454. DOI: 10.1016/j.anai.2023.10.032.
89.
HodgkinsonCP. Physiology of the ovarian veins during pregnancy. Obstet Gynecol1953; 1(1): 26–37.
90.
BasantsovaNYStarshinovaAADoriA, et al.Small-fiber neuropathy definition, diagnosis, and treatment. Neurol Sci2019; 40(7): 1343–1350. DOI: 10.1007/s10072-019-03871-x.
91.
CastroRAVernettiPMBiaggioniI, et al.Long-Term outcomes of hyperadrenergic orthostatic hypotension. Res Sq2023; 3. DOI: 10.21203/rs.3.rs-3318273/v1.
92.
MoriKIijimaMKoikeH, et al.The wide spectrum of clinical manifestations in Sjogren's syndrome-associated neuropathy. Brain2005; 128(Pt 11): 2518–2534. DOI: 10.1093/brain/awh605.
93.
ChelimskyGKovacicKNugentM, et al.Comorbid conditions do not differ in children and young adults with functional disorders with or without postural tachycardia syndrome. J Pediatr2015; 167(1): 120–124. DOI: 10.1016/j.jpeds.2015.03.039.
94.
LaszloJGyoryG. Pathogenesis of pelvic pain. Am J Obstet Gynecol1963; 85(2): 141–148.
95.
Baeza-VelascoCVan den BosscheTGrossinD, et al.Difficulty eating and significant weight loss in joint hypermobility syndrome/Ehlers-Danlos syndrome, hypermobility type. Eat Weight Disord2016; 21(2): 175–183. DOI: 10.1007/s40519-015-0232-x.
96.
NguyenLWilsonLAMirielLNIDDK Gastroparesis Clinical Research Consortium GpCRC, et al. Autonomic function in gastroparesis and chronic unexplained nausea and vomiting: relationship with etiology, gastric emptying, and symptom severity. Neuro Gastroenterol Motil2020; 32(8): e13810. DOI: 10.1111/nmo.13810.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
